Byetta (exenatide)
BYETTA (exenatide) – a glucagon-like peptide-1 (GLP-1) receptor agonist commonly used to treat type 2 adult diabetes mellitus. FDA approved uses: Byetta is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Available dosage forms: Solution for subcutaneous injection, prefilled multi-dose pen delivering doses of […]